Login / Signup

Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.

Laura MezquitaMarianne OulhenAgathe AberlencMarc DelogerMihaela AldeaAurélie HonoreYann LecluseKaren HowarthLuc FribouletBenjamin BesseDavid PlanchardFrançoise Farace
Published in: British journal of cancer (2024)
-mutant NSCLC, including relevant alterations that may represent potential treatment opportunities.
Keyphrases
  • wild type
  • single cell
  • small cell lung cancer
  • cell therapy
  • stem cells
  • combination therapy
  • tyrosine kinase
  • epidermal growth factor receptor
  • smoking cessation